Serum Provitamin D kinetic upon oral intake
- Conditions
- Vitamin D supplementationNot Applicable
- Registration Number
- ISRCTN65263333
- Lead Sponsor
- Charité - Universitätsmedizin Berlin (Germany)
- Brief Summary
2017 Results article in https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256876/ (added 14/04/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 43
1. Healthy individuals, patients with type I allergy
2. Age 18-60 years
3. No excessive tanning in last 4 weeks
4. Written informed consent
1. Simultaneous participation in an other study
2. Expected incompliance
3. Pregnancy, lactation
4. Disease of the cardiovascular system, kidneys, thyroid gland
5. Malignant diseases
6. Malabsorbtion
7. Chronic infections
8. Planned exzessive tanning during the investigation time
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Achievement of serum 25-hydroxyvitamin D concentrations above 100 nM on screening visits and 4 monthly study visits
- Secondary Outcome Measures
Name Time Method <br> 1. Serum concentrations of calcium, phosphorus, creatinine<br> 2. Monitor activation and phenotype of peripheral lymphocytes<br><br> Assesed on screening visits and 4 monthly study visits<br>